by The human microbiome market comprises of products essential in understanding the composition and role of microorganisms present inside and on humans. This includes sequencing instruments, extraction and sequencing kits, analysis tools, and consulting services. Advancements in sequencing technologies have enabled researchers to identify microbes efficiently, unveiling their connection with human health and diseases. These products enable researchers to understand how the microbiome regulates immune system responses, energy extraction from foods, synthesis of certain vitamins and gut-brain axis communication.
The Global human microbiome market Demand is estimated to be valued at US$ 4894.33 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the human microbiome market are Diageo plc, Pernod-Ricard SA, Constellation Brands Inc., Brown-Forman Corporation, Remy Cointreau SA, Marie Brizard Wine & Spirits, Lapostolle SA, and Berentzen-Gruppe AG. Sequencing companies like Illumina and Thermo Fisher are also venturing into analysis software and databases. The growing awareness regarding the role of gut health is accelerating the demand for microbiome testing and therapeutics. Various startups are introducing novel probiotic formulations and testing services to leverage this opportunity.
Rising applications of microbiome studies in new disease areas like cancer, obesity, and neurodegenerative disorders are fueling the adoption. Researchers are exploring how alterations in the microbiome composition correlate with these conditions. Microbiome-based diagnostics and therapeutics hold promise for affordable personalized care by modulating microbiota. Rapid customization using next-generation sequencing platforms is gaining traction for clinical research.
Key players are expanding their geographic presence through acquisitions and partnerships. This helps gain access to new customer segments and strengthen product portfolios. For instance, Illumina collaborated with European Bioinformatics Institute to boost metagenomics analysis capabilities. Firms are building sample and data repositories to power predictive disease modelling using AI. This paves way for open innovation and precision preventive healthcare approaches based on gut-brain interactions.
Market key trends
One of the major trends gaining prominence in the human microbiome market is increasing fecal microbiota transplantation (FMT) to treat various healthcare issues. FMT involves restoration of the gut microbial community from a healthy individual into a recipient’s intestine with the aim to cure metabolic disorders like obesity and diabetes. It has shown promise for managing intestinal diseases like clostridium difficile infection and inflammatory bowel disease as well. Researchers are evaluating the role of microbiota manipulation using FMT in managing neurological conditions like autism, depression and Parkinson’s disease, based on gut-brain signalling.
Porter’s Analysis
Threat of new entrants: Low barrier of entry due to low capital investment required in R&D and manufacturing.
Bargaining power of buyers: High bargaining power due to availability of substitutes and undifferentiated products.
Bargaining power of suppliers: Low bargaining power of suppliers due to availability of substitutes.
Threat of new substitutes: High threat due to availability of a wide range of probiotics and prebiotics products.
Competitive rivalry: Intense competitive rivalry between existing players to gain higher market share.
Geographically, North America region accounts for the largest share of the human microbiome market in terms of value mainly due to the increasing geriatric population, rising prevalence of chronic diseases, growing health awareness. Asia Pacific region is expected to grow at the fastest CAGR during the forecast period owing to surging demand for probiotic dietary supplements, growing disposable income, improving healthcare infrastructure.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
